EUVIMEDEUVIMED entdecken
Crossref

Pterostilbene Inhibits Hepatocellular Carcinoma by Regulating the MAPK Signaling Pathway

MEDS Public Health and Preventive Medicine · 2026 · 6

DOI: 10.23977/phpm.2026.060108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MEDS Public Health and Preventive Medicine, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Pterostilbene Inhibits Hepatocellular Carcinoma by Regulating the MAPK Signaling Pathway. MEDS Public Health and Preventive Medicine, 6. https://doi.org/10.23977/phpm.2026.060108

Vancouver

Pterostilbene Inhibits Hepatocellular Carcinoma by Regulating the MAPK Signaling Pathway. MEDS Public Health and Preventive Medicine. 2026;6. doi:10.23977/phpm.2026.060108

BibTeX
@article{euvimed2026,
  title = {Pterostilbene Inhibits Hepatocellular Carcinoma by Regulating the MAPK Signaling Pathway},
  journal = {MEDS Public Health and Preventive Medicine},
  year = {2026},
  volume = {6},
  doi = {10.23977/phpm.2026.060108}
}
Kostenlos starten →